These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26323431)

  • 1. (Phospho)lipid-based Nanosystems for Skin Administration.
    Vanić Z; Holæter AM; Skalko-Basnet N
    Curr Pharm Des; 2015; 21(29):4174-92. PubMed ID: 26323431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanodelivery systems for improved topical antimicrobial therapy.
    Basnet P; Škalko-Basnet N
    Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical Nano-emulgel for Skin Disorders: Formulation Approach and Characterization.
    Ahmad J; Gautam A; Komath S; Bano M; Garg A; Jain K
    Recent Pat Antiinfect Drug Discov; 2019; 14(1):36-48. PubMed ID: 30488798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles in dermatology.
    Papakostas D; Rancan F; Sterry W; Blume-Peytavi U; Vogt A
    Arch Dermatol Res; 2011 Oct; 303(8):533-50. PubMed ID: 21837474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders.
    Desmet E; Van Gele M; Lambert J
    Expert Opin Drug Deliv; 2017 Jan; 14(1):109-122. PubMed ID: 27348356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery and targeting of nanoparticles into hair follicles.
    Fang CL; Aljuffali IA; Li YC; Fang JY
    Ther Deliv; 2014; 5(9):991-1006. PubMed ID: 25375342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Going skin deep: A direct comparison of penetration potential of lipid-based nanovesicles on the isolated perfused human skin flap model.
    Ternullo S; de Weerd L; Holsæter AM; Flaten GE; Škalko-Basnet N
    Eur J Pharm Biopharm; 2017 Dec; 121():14-23. PubMed ID: 28916504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current State of Nanomedicines in the Treatment of Topical Infectious Disorders.
    Thakur K; Sharma G; Singh B; Chhibber S; Katare OP
    Recent Pat Antiinfect Drug Discov; 2018; 13(2):127-150. PubMed ID: 29807522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silica-based nanosystems for therapeutic applications in the skin.
    Arriagada F; Nonell S; Morales J
    Nanomedicine (Lond); 2019 Aug; 14(16):2243-2267. PubMed ID: 31411537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cubic Phases, Cubosomes and Ethosomes for Cutaneous Application.
    Esposito E; Drechsler M; Nastruzzi C; Cortesi R
    Curr Pharm Des; 2016; 22(35):5382-5399. PubMed ID: 27839503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
    Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
    Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in encapsulated dermal formulations in chemoprevention of melanoma: An overview.
    Ravikumar P; Tatke P
    J Cosmet Dermatol; 2019 Dec; 18(6):1606-1612. PubMed ID: 31436386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid nanocarriers as skin drug delivery systems: Properties, mechanisms of skin interactions and medical applications.
    Sala M; Diab R; Elaissari A; Fessi H
    Int J Pharm; 2018 Jan; 535(1-2):1-17. PubMed ID: 29111097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical and cutaneous delivery using nanosystems.
    Roberts MS; Mohammed Y; Pastore MN; Namjoshi S; Yousef S; Alinaghi A; Haridass IN; Abd E; Leite-Silva VR; Benson H; Grice JE
    J Control Release; 2017 Feb; 247():86-105. PubMed ID: 28024914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid vesicles and other colloids as drug carriers on the skin.
    Cevc G
    Adv Drug Deliv Rev; 2004 Mar; 56(5):675-711. PubMed ID: 15019752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanosystems in Photoprotection.
    Coutinho Cdos S; Dos Santos EP; Mansur CR
    J Nanosci Nanotechnol; 2015 Dec; 15(12):9679-88. PubMed ID: 26682396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine strategies for targeting skin inflammation.
    Abdel-Mottaleb MM; Try C; Pellequer Y; Lamprecht A
    Nanomedicine (Lond); 2014 Aug; 9(11):1727-43. PubMed ID: 25321172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid nanoparticles as novel delivery systems for cosmetics and dermal pharmaceuticals.
    Puglia C; Bonina F
    Expert Opin Drug Deliv; 2012 Apr; 9(4):429-41. PubMed ID: 22394125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicines to Treat Skin Pathologies with Natural Molecules.
    Esposito E; Nastruzzi C; Sguizzato M; Cortesi R
    Curr Pharm Des; 2019; 25(21):2323-2337. PubMed ID: 31584367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanovesicles for Nanomedicine: Theory and Practices.
    Wadhwa S; Garg V; Gulati M; Kapoor B; Singh SK; Mittal N
    Methods Mol Biol; 2019; 2000():1-17. PubMed ID: 31148004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.